Antineoplasic Drug Methotrexate Redox Mechanism Using a Glassy Carbon Electrode

27Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Methotrexate (MTX) is an antimetabolite of folic acid indicated in the treatment of a variety of cancers. The electrochemical behaviour of MTX on a glassy carbon electrode was investigated. The MTX oxidation is a complex, pH-dependent, diffusion-controlled irreversible process and proceeds with the transfer of two electrons and two protons and the formation of one electroactive product, 7-hydroxymethotrexate that undergoes a reversible redox reaction. The MTX reduction is a pH-dependent, quasi-reversible process and involves the transfer of two electrons and two protons leading to the formation of an electroactive product. © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Cite

CITATION STYLE

APA

Pontinha, A. D. R., Jorge, S. M. A., Diculescu, V. C., Vivan, M., & Oliveira-Brett, A. M. (2012). Antineoplasic Drug Methotrexate Redox Mechanism Using a Glassy Carbon Electrode. Electroanalysis, 24(4), 917–923. https://doi.org/10.1002/elan.201100558

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free